Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
What Is A Glide Path In Target Date Funds
Glide paths in target date funds describe how asset allocations shift automatically as retirement nears, balancing growth and risk over time. This intro explains the idea and why it matters for planning.
25,488 articles
UCO Rises 125% This Year, Hidden Structural Risk Looms
ProShares Ultra Bloomberg Crude Oil 2x (UCO) has surged about 125% this year, yet traders warn a hidden structural ri...
Intel Surges 5% Today Amid Tenstorrent Talks: Here’s Why
Intel stock climbs about 5% after word that the company is in talks to acquire AI accelerator startup Tenstorrent, re...
Trade Desk Down This Year Sparks Ad-Tech Stock Debate
Ad-tech leaders Trade Desk and AppLovin face renewed scrutiny in 2026 as AI investments pressure margins and trigger ...
AMD Stock 5-Year Prediction as AI Demand Surges Higher
AMD's quarterly results show data-center strength lifting the growth story. This piece maps a 5-year prediction stock...
Tesla’s Self-Driving Future Hit by Waymo’s New York Setback
New York Governor Hochul’s decision to pause autonomous for-hire vehicle expansion outside NYC hits Waymo and Tesla’s...
Ramsey’s Blunt Statement to Millionaire’s Parents Sparks
A caller in his 60s with a six-figure income and no retirement savings since 2008 receives a blunt reality check on T...
Should XRP, Solana, with $1,000 Make Sense in 2026?
As Q2 2026 gains momentum, XRP, Solana, and BNB post modest climbs. Investors eye price thresholds and upcoming catal...
Here's Rivian Stock Jumped: Why It Surged This Week
Rivian stock moved higher this week without a formal press release, boosted by direct investor outreach and renewed i...
Cramer: Cheap Still Cheaper — Salesforce Skeptics Persist
Jim Cramer remains wary of Salesforce as growth slows and CIOs shift budgets to less expensive software. He argues th...
Axon Enterprise Earnings Preview: Wall Street Watches Q4
Axon is set to report Q4 2025 results after the close, as Wall Street weighs software momentum, AI-era bookings, and ...
Arm's Chip Game Changer: Is It Time to Buy ARM Stock Now
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status